Ledger.Open graph →
SEC Form D · filed September 11, 2015

Aclaris Therapeutics, Inc

Offering
$40.0M
Sold
$40.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
MALVERN, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Christopher A. Molineaux · Malvern, PADirectorAnand A. Mehra · Malvern, PADirectorItai Danino · San Francisco, CAExec · DirectorAlbert A. Cha · Malvern, PADirectorJustin G. Gorenkoff · New York, NYExec · DirectorLee Taylor · Boston, MAExecChristopher Powala · Malvern, PAExecFrank D. Ruffo · Malvern, PAExecEden Shochat · San Francisco, CAExecAlbert A. Cha · Malvern, PADirectorStuart Browne · SCOTTSDALE, AZExecIndia GP LLC · Santa Monica, CAExecKamil D. Ali-Jackson · Malvern, PAExecDaniel G. Goldberg · New York, NYExec · DirectorKetan A. Patel · Malvern, PADirectorKetan A. Patel · Malvern, PADirectorBill Mccullen · Boston, MADirectorNeal Walker · Malvern, PAExec · DirectorStephen A. Tullman · Malvern, PADirectorStuart D. Shanler · Malvern, PAExecAnand A. Mehra · Malvern, PADirectorChristopher A. Molineaux · Malvern, PADirectorJonathan R. Baldwin · New York, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗